The STERIS Plc has seen significant financial activity in the past period. Various asset management firms including Wealthfront Advisers, Emerald Advisers, and Brighton Jones have been investing heavily in the firm while Envestnet Asset Management and Bessemer Group shrank their holdings. Other financial entities like Fjarde AP Fonden, US Bancorp, and Mutual of America Capital Management also adjusted their stakes. Despite the CEO selling a number of shares, the overall sentiment seems positive with new investments from firms like AustralianSuper Pty, Equitable Trust, and 111 Capital. The company has also set a quarterly dividend of $0.63 per share and will host a conference call to discuss the fiscal Q2 2026 results. Analysts are speculating about the growth potential of STERIS and a potential 13.39% potential upside is suggested. With strong Q1 fiscal 2026 results, a 9% revenue growth and an improved financial outlook, the prospects look promising. STERIS also elevated its revenue guidance for 2026 and announced a CFO transition. The overall picture for STE seems like a mix of significant institutional investments, robust earnings, and strategic financial moves.
Steris Plc STE News Analytics from Sat, 26 Apr 2025 07:00:00 GMT to Sat, 01 Nov 2025 08:50:51 GMT - Rating 7 - Innovation 5 - Information 9 - Rumor 2
